Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
17.2M
-
Number of holders
-
49
-
Total 13F shares, excl. options
-
4.37M
-
Shares change
-
-6.13M
-
Total reported value, excl. options
-
$12M
-
Value change
-
-$15.9M
-
Put/Call ratio
-
0.05
-
Number of buys
-
43
-
Number of sells
-
-3
-
Price
-
$2.74
Significant Holders of UNITY BIOTECHNOLOGY, INC. - Common Stock, par value $0.0001 per share (UNBX) as of Q4 2022
56 filings reported holding UNBX - UNITY BIOTECHNOLOGY, INC. - Common Stock, par value $0.0001 per share as of Q4 2022.
UNITY BIOTECHNOLOGY, INC. - Common Stock, par value $0.0001 per share (UNBX) has 49 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.37M shares
of 17.2M outstanding shares and own 25.37% of the company stock.
Largest 10 shareholders include ARCH Venture Management, LLC (1M shares), FMR LLC (763K shares), Alyeska Investment Group, L.P. (697K shares), VANGUARD GROUP INC (444K shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (250K shares), 683 Capital Management, LLC (240K shares), ACADIAN ASSET MANAGEMENT LLC (105K shares), RENAISSANCE TECHNOLOGIES LLC (91.2K shares), GEODE CAPITAL MANAGEMENT, LLC (91.1K shares), and ExodusPoint Capital Management, LP (75.9K shares).
This table shows the top 49 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.